Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study

References

• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529–539. doi:10.1007/s00281-017-0629-x
   PubMed Web of Science ®Google Scholar
• Hirsch J, Ng J, Ross D, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98:209–218. doi:10.1016/j.kint.2020.05.006
   PubMed Web of Science ®Google Scholar
• Ronco C, Reis T, De Rosa S. Coronavirus epidemic and extracorporeal therapies in intensive care: si vis pacem para bellum. Blood Purif. 2020;49:255–258. doi:10.1159/000507039
   PubMed Web of Science ®Google Scholar
• Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi:10.1126/science.abb8925
   PubMed Web of Science ®Google Scholar
• Lh D, Widiasta A, Ghrahani R, Hilmanto D, Rachmadi D. Therapeutic plasma exchange as a promising therapeutic modality in the management of acute cytokine storms and secondary prevention of chronic kidney disease in children during pandemic. Int J Pharm Res. 2022. doi:10.31838/ijpr/2021.13.02.259
   Google Scholar
• Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet. 2020;229. doi:10.1016/S2213-2600(20)30229-0
   Web of Science ®Google Scholar
• Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nature Reviews Nephr. 2020;16:308–310. doi:10.1038/s41581-020-0284-7
   PubMed Web of Science ®Google Scholar
• Stamm O, Latscha U, Janecek P, Campana A. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138. doi:10.1016/s0002-9378(16)33297-5
   Web of Science ®Google Scholar
• Monard C, Rimmelé T, Ronco C. Extracorporeal blood purification therapies for sepsis. Blood Purif. 2019;47((suppl 3):):2–15. doi:10.1159/000499520
   PubMed Web of Science ®Google Scholar
• Ponce D, Abrão JM, Albino BB, et al. Extended daily dialysis in acute kidney injury patients: metabolic and fluid control and risk factors for death. PLoS One. 2013;8:e81697. doi:10.1371/journal.pone.0081697
   PubMed Web of Science ®Google Scholar
• Albino BB, Balbi AL, Abrao JM, et al. Dialysis complications in acute kidney injury patients treated with prolonged intermittent renal replacement therapy sessions lasting 10 versus 6 hours: results of a randomized clinical trial. Artif Organs. 2015;39:423–431. doi:10.1111/aor.12408
   PubMed Web of Science ®Google Scholar
• Fieghen HE, Friedrich JO, Burns KE, et al. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury. BMC Nephrol. 2010;11:32. doi:10.1186/1471-2369-11-32
   PubMed Web of Science ®Google Scholar
• Marshall MR, Ma T, Galler D, et al. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant. 2004;19:877–884. doi:10.1093/ndt/gfg625
   PubMed Web of Science ®Google Scholar
• Holt BG, White JJ, Kuthiala A, et al. Sustained low-efficiency daily dialysis with hemofiltration for acute kidney injury in the presence of sepsis. Clin Nephrol. 2008;69:40–46. doi:10.5414/CNP69040
   PubMed Web of Science ®Google Scholar
• Kumar VA, Yeun JY, Depner TA, et al. Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs. 2004;27:371–379. doi:10.1177/039139880402700505
   PubMed Web of Science ®Google Scholar
• Rachmadi D, Widiasta A, Sukandar H, Sekarwana N, Hilmanto D. The association between kidney function and the severity of COVID-19 in children. Open Access Maced J Med Sci. 2022;10(B):1473–1478. doi:10.3889/oamjms.2022.9784
   Google Scholar
• Chen G, Zhou Y, Ma J, Xia P, Qin Y, Li X. Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? Ren Fail. 2020;42(1):483–488. doi:10.1080/0886022X.2020.1764369
   PubMed Web of Science ®Google Scholar
• Villa G, Zaragoza JJ, Sharma A, Neri M, Gaudio R, Ronco C. Cytokine removal with high cut-off membrane: review of literature. Blood Purif. 2014;38:167–173. doi:10.1159/000369155
   PubMed Web of Science ®Google Scholar
• Madelaine T, Page M, Prothet J, et al. Super high-flux continuous hemodialysis in septic shock: a case report. Nephrol Ther. 2013;9:497–500. doi:10.1016/j.nephro.2013.07.370
   PubMed Web of Science ®Google Scholar
• Kade G, Wiśniewska M, Lubas A, Rzeszotarska A, Korsak J. The treatment of septic shock with continuous venovenous hemodialysis using high cut-off dialyzer in patient after immediate circulatory arrest. Przegl Lek. 2013;70:698–700. doi:10.1016/0002-9378(76)90154-x
   PubMedGoogle Scholar
• Chelazzi C, Giugni D, Giannoni C, Villa G, De Gaudio AR. Use of continuous venovenous hemodiafiltration with a high cutoff membrane in a patient with severe acute pancreatitis. J Nephrol. 2012;2:78–81.
   Google Scholar
• Ronco C, Bonello M, Bordoni V, et al. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif. 2004;22:164–174. doi:10.1159/000074937
   PubMed Web of Science ®Google Scholar
• Villa G, Romagnoli S, De Rosa S, et al. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study. Critical Care. 2020;24:605.
   PubMed Web of Science ®Google Scholar
• Mayeur N, Rostaing L, Nogier MB, et al. Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure. Critical Care. 2010;14:R115. doi:10.1186/cc9064
   PubMed Web of Science ®Google Scholar